Teva launches first-to-file generic Cialis

Sep 27, 2018

Teva Pharmaceutical Industries announced the exclusive first-to-file launch of a generic version of Eli Lilly’s Cialis tablets in the U.S.

First-to-file status grants Teva a 180-day period of market exclusivity before the FDA approves another generic.

The launch builds on the generic giant’s portfolio, and follows an exclusive launch of a generic version of Viagra. According to Teva, the drugmaker  has the largest portfolio of FDA-approved generic products on the market and holds the leading position in first-to-file opportunities, with over 100 pending first-to-files in the U.S.

Read the press release

Want to get content like this in your inbox?  Subscribe to our eNewsletter here!